UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 76 filers reported holding UROGEN PHARMA LTD in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,069,969 | +47.0% | 219,127 | +8.6% | 0.00% | – |
| Q2 2023 | $2,087,812 | +1471.7% | 201,721 | +1303.2% | 0.00% | – |
| Q1 2023 | $132,834 | +104493.7% | 14,376 | 0.0% | 0.00% | – |
| Q4 2022 | $127 | -99.9% | 14,376 | 0.0% | 0.00% | – |
| Q3 2022 | $119,000 | +1.7% | 14,376 | 0.0% | 0.00% | – |
| Q2 2022 | $117,000 | -92.4% | 14,376 | -91.8% | 0.00% | – |
| Q1 2022 | $1,534,000 | -3.8% | 176,213 | +5.0% | 0.00% | – |
| Q4 2021 | $1,595,000 | -38.5% | 167,757 | +8.8% | 0.00% | – |
| Q3 2021 | $2,593,000 | +2.6% | 154,185 | -6.9% | 0.00% | – |
| Q2 2021 | $2,528,000 | -21.4% | 165,595 | +0.3% | 0.00% | – |
| Q1 2021 | $3,217,000 | +21.8% | 165,165 | +12.6% | 0.00% | – |
| Q4 2020 | $2,642,000 | -7.8% | 146,642 | -1.3% | 0.00% | -100.0% |
| Q3 2020 | $2,866,000 | -26.3% | 148,605 | -0.2% | 0.00% | 0.0% |
| Q2 2020 | $3,889,000 | +58.5% | 148,917 | +8.2% | 0.00% | 0.0% |
| Q1 2020 | $2,454,000 | -70.0% | 137,585 | -43.9% | 0.00% | 0.0% |
| Q4 2019 | $8,178,000 | +212.7% | 245,088 | +123.3% | 0.00% | 0.0% |
| Q3 2019 | $2,615,000 | -30.1% | 109,764 | +5.5% | 0.00% | 0.0% |
| Q2 2019 | $3,739,000 | +550.3% | 104,050 | +568.1% | 0.00% | – |
| Q1 2019 | $575,000 | -17.6% | 15,575 | -4.2% | 0.00% | – |
| Q4 2018 | $698,000 | +82.2% | 16,250 | +100.0% | 0.00% | – |
| Q3 2018 | $383,000 | +7.9% | 8,125 | +13.7% | 0.00% | – |
| Q2 2018 | $355,000 | 0.0% | 7,145 | 0.0% | 0.00% | – |
| Q1 2018 | $355,000 | +34.0% | 7,145 | 0.0% | 0.00% | – |
| Q4 2017 | $265,000 | +17.8% | 7,145 | 0.0% | 0.00% | – |
| Q3 2017 | $225,000 | – | 7,145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
| Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
| Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
| MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
| DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
| SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
| BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
| Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |